Call Options
ULTA POPS 48 DOLLARS BUY THE DIPS NOW
Try our free 5 day trial today https://turbooptiontrading.com/2024/01/05/free-5-day-trial/ 1. Earnings Reports: Ulta’s quarterly earnings reports are critical. Positive earnings surprises can boost the stock, while negative surprises can lead to declines. For the current quarter, Ulta is expected to post earnings of $5.49 per share1. 2. Consumer Spending Trends: As a retailer, Ulta’s performance is […]
Put Options
ADBE 590 PUT OPTIONS BIG PAYDAY
Try our free 5 day trial today https://turbooptiontrading.com/2024/01/05/free-5-day-trial/ 1. Revenue Guidance: For the upcoming quarter, Adobe has guided revenue to be between $5.1 billion and $5.15 billion1. This was slightly below Wall Street’s expectations, which contributed to a drop in the stock price2. 2. Earnings Per Share (EPS): The company expects adjusted EPS to be […]
Top Gainers
DELL BEAT EARNINGS POP
Try our free 5 day trial today https://turbooptiontrading.com/2024/01/05/free-5-day-trial/ Here are some key highlights: • Revenue: Dell reported revenue of $25.06 billion, surpassing the expected $24.53 billion2. • Earnings Per Share (EPS): Adjusted EPS came in at $1.89, higher than the anticipated $1.712. • Net Income: The net income rose significantly to $841 million from $455 […]
Top Losers
Saturday Indexes the proof is there watch now
Try our free 5 day trial today https://turbooptiontrading.com/2024/01/05/free-5-day-trial/ The recent market volatility has been driven by several factors: Economic Data: Weak manufacturing data has renewed fears of a potential economic slowdown in the U.S.1. Earnings Reports: Big tech earnings have been a significant contributor. Investors reacted strongly to the quarterly results of major tech companies […]
Indexes
RUI INDEX 1000 TOPPING OUT AT HIGHS
Try our free 5 day trial today https://turbooptiontrading.com/2024/01/05/free-5-day-trial/ The Russell 1000 Index and the S&P 500 are both widely used benchmarks for large-cap U.S. stocks, but they have some key differences: 1. Composition: o S&P 500: Includes 500 of the largest U.S. companies, strictly large-cap stocks. o Russell 1000: Includes 1,000 of the largest U.S. […]
Free Stock Plays
ARM BUY THE DIPS EVERY TIME
Try our free 5 day trial today https://turbooptiontrading.com/2024/01/05/free-5-day-trial/ Market Position and Business Model • Arm Holdings: Primarily designs and licenses its chip architectures to other companies, which then manufacture and sell the chips. This model allows Arm to maintain a high gross margin (over 90%) and focus on innovation1. • Intel: An integrated device manufacturer […]
Earnings Beat
Cracker Barrel to Report Q4 Earnings: Is a Beat in Store?
Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is scheduled to report fourth-quarter fiscal 2024 results on Sept. 19. In the last reported quarter, CBRL registered an earnings surprise of 57.1%. Trend in Estimate Revision The Zacks Consensus Estimate for fiscal fourth-quarter earnings per share is pegged at $1.17, which indicates a deterioration of 34.6% […]
Earnings Miss
Designer Brands’ Q2 Earnings Miss Estimates, Comps Decline Y/Y
Designer Brands Inc. (NYSE: DBI) released second-quarter fiscal 2024 results, wherein both the bottom and top lines lagged the Zacks Consensus Estimate and declined year over year. However, during the second quarter, the company continued to advance with its strategic initiatives aimed at business transformation. Despite challenges in categories like dress and seasonal footwear, the […]
Upgrades
North Face Parent V.F. Corp To Improve Gradually In Next Four To Six Quarters, Analyst Upgrades Stock
Barclays analyst Adrienne Yih upgraded V.F. Corporation (NYSE:VFC) from Equal-Weight to Overweight, raising the price forecast from $19 to $22. The analyst forecasts that the company will start to experience gradual improvements in its fundamentals over the next four to six quarters, beginning modestly in the fall of 2024. By the time the analyst anticipates a return to […]
Downgrades
Incyte Downgraded – Analyst Notes Intense Competition, Particularly In Larger Markets
Truist Securities has downgraded Incyte Corporation (NASDAQ:INCY), noting Jakafi’s (ruxolitinib) patent loss approaching in 2028. Jakafi is Incyte’s top-selling drug. It is indicated for polycythemia vera in adults, intermediate or high-risk myelofibrosis in adults, and steroid-refractory acute graft versus host disease in adult and pediatric patients. In second quarter 2024, the drug generated sales of $705.9 […]
ETFs
Soxx starting to move up higher
Try our free 5 day trial today https://turbooptiontrading.com/2024/01/05/free-5-day-trial/ The top holdings in the iShares Semiconductor ETF (SOXX) are as follows12: 1. Broadcom Inc. (AVGO) – 9.93% 2. NVIDIA Corporation (NVDA) – 8.82% 3. Advanced Micro Devices, Inc. (AMD) – 7.21% 4. Applied Materials, Inc. (AMAT) – 5.89% 5. QUALCOMM Incorporated (QCOM) – 5.51% 6. Monolithic […]
Hall Of Fame
MSTR 1300 PUT OPTIONS
Try our free 5 day trial today https://turbooptiontrading.com/2024/01/05/free-5-day-trial/ Michael Saylor’s Sell-Off: Michael Saylor, the executive chairman of MicroStrategy, sold shares worth $20 million ahead of the SEC’s Bitcoin ETF approval1. This move raised concerns among investors, leading to a decline in MicroStrategy’s stock price by 23%1. Bitcoin Holdings: Despite the sell-off, MicroStrategy continues to hold […]